AstraZeneca Temporarily Pauses COVID-19 Vaccine Trial After Participant May Have Suffered Adverse Reaction
(CBS) -- AstraZeneca on Tuesday temporarily halted its phase three trial of a possible coronavirus vaccine after one participant may have suffered from a serious adverse reaction.
